LETROZOLE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Letrozole, and what generic alternatives are available?
Letrozole is a drug marketed by Accord Hlthcare, Actavis Totowa, Apotex Inc, Beijing Yiling, Chartwell Rx, Eugia Pharma, Fresenius Kabi Usa, Hikma, Hikma Pharms, Impax Labs, Indicus Pharma, Lannett Co Inc, Natco Pharma Ltd, Norvium Bioscience, Ryan Labs, Strides Pharma, Sun Pharm Inds Ltd, Synthon Pharms, and Teva Pharms. and is included in twenty NDAs.
The generic ingredient in LETROZOLE is letrozole. There are twenty-four drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the letrozole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Letrozole
A generic version of LETROZOLE was approved as letrozole by ACCORD HLTHCARE on June 3rd, 2011.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LETROZOLE?
- What are the global sales for LETROZOLE?
- What is Average Wholesale Price for LETROZOLE?
Summary for LETROZOLE
| US Patents: | 0 |
| Applicants: | 19 |
| NDAs: | 20 |
| Finished Product Suppliers / Packagers: | 15 |
| Raw Ingredient (Bulk) Api Vendors: | 135 |
| Clinical Trials: | 596 |
| Patent Applications: | 4,353 |
| Drug Prices: | Drug price information for LETROZOLE |
| Drug Sales Revenues: | Drug sales revenues for LETROZOLE |
| DailyMed Link: | LETROZOLE at DailyMed |
Recent Clinical Trials for LETROZOLE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mridula George, MD | Phase 1 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 4 |
| Verastem, Inc. | Phase 3 |
Pharmacology for LETROZOLE
| Drug Class | Aromatase Inhibitor |
| Mechanism of Action | Aromatase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for LETROZOLE
US Patents and Regulatory Information for LETROZOLE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accord Hlthcare | LETROZOLE | letrozole | TABLET;ORAL | 090934-001 | Jun 3, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sun Pharm Inds Ltd | LETROZOLE | letrozole | TABLET;ORAL | 091466-001 | Jun 3, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fresenius Kabi Usa | LETROZOLE | letrozole | TABLET;ORAL | 090491-001 | Jun 3, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
